Blake Borgeson - 03 Oct 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
03 Oct 2022
Net transactions value
$0
Form type
4
Filing time
05 Oct 2022, 21:10:50 UTC
Previous filing
06 Jul 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +920 +0.01% $0.000000 7,672,697 03 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were issued in accordance with the Issuer's Outside Director Compensation Policy.